Treated by Dr. Ravi Chandra Reddy Obili at Dr Ravi Chandra Reddy
Intrahepatic cholangiocarcinoma is a type of cancer that starts in the bile ducts inside the liver. These ducts carry bile, a digestive fluid, from the liver to the intestine. This cancer is uncommon and can be difficult to detect early because symptoms often appear only after the tumour has grown. Dr Ravi Chandra Reddy evaluates and manages patients with this condition, working through careful assessment and individualised treatment planning.
A distinct tumour mass forms within the liver tissue, appearing as a solid lump on imaging.
The cancer grows along the bile ducts, thickening and narrowing them without forming a discrete mass.
The tumour grows inside the bile duct lumen, sometimes spreading along the duct wall.
Multiple factors can contribute to the development and progression of this condition.
Recognising the signs early gives you more treatment options.
Evaluation begins with a detailed clinical history and physical examination, followed by blood tests and imaging to assess the liver and bile ducts. Not every patient requires every investigation; the approach is tailored to the individual presentation.
From conservative to surgical — we always start with the least invasive option first.
A structured, patient-first approach from first visit to full recovery.
Dr Ravi Chandra Reddy reviews your medical history, symptoms, and any previous test results, then performs a thorough physical examination to understand your condition.
Based on the initial findings, appropriate blood tests, imaging studies, and biopsy are arranged to confirm the diagnosis and assess the extent of disease.
A personalised treatment plan is developed, considering the tumour stage, liver function, and your overall health. Options are discussed in detail, including potential risks and benefits.
Treatment is coordinated with medical oncologists and other specialists as needed. Regular follow-up ensures progress is monitored and any complications are addressed promptly.
What to expect at each phase of recovery.
The first few weeks focus on managing any side effects from chemotherapy or recovering from surgery. Timelines vary, and individual guidance takes priority.
As strength returns, focus shifts to rebuilding nutrition, managing symptoms, and regular imaging to monitor the tumour. Support from family and care teams is important.
Ongoing follow-up with blood tests and scans is planned to watch for changes or recurrence. The frequency and type of monitoring depend on the treatment received and response.
Good management can reduce pain, jaundice, and other symptoms, helping maintain daily function and comfort. However, the cancer itself may remain a chronic challenge.
Treatment aims to slow cancer growth and, where possible, remove it. Not all patients achieve long-term remission, and outcomes vary widely based on stage and response.
Careful planning can preserve enough healthy liver tissue to maintain function. However, advanced disease or complications may limit this.
Each patient's response to treatment is different. Some achieve prolonged stability, while others may face progression despite therapy. Realistic goal-setting is part of the care process.
Without treatment, intrahepatic cholangiocarcinoma typically progresses, with the tumour growing and spreading to other parts of the liver or beyond. Symptoms such as jaundice, pain, and weight loss often worsen over time. Early assessment and management can help address symptoms and may offer options to slow disease progression.
Seek medical attention if you develop persistent yellowing of the skin or eyes, unexplained weight loss, ongoing upper abdominal pain, or dark urine with pale stools. Early evaluation is important, especially if you have a history of liver disease or chronic bile duct conditions.
Early treatment means more options and better outcomes. Book a consultation to understand your condition and explore the right path forward.
